Nav: Home

Scientists unearth secrets of Sir Alexander Fleming's medical breakthroughs

February 15, 2018

A century after Sir Alexander Fleming made two of the most important medical breakthroughs, scientists have unlocked the secret of how his discoveries may contribute to recurrent patient infections.

Fleming's best-known findings are the enzyme lysozyme - found in tears and many body secretions - and penicillin, perhaps the most significant medical revelation of all time.

Now, for the first time, experts at Newcastle University, UK, whose study is published online today in Cell, have identified how lysozyme and penicillin could work in combination to cause recurrent infections.

It is hoped that this study will prompt a re-evaluation of looking at why some patients with health complaints, such as urinary tract or streptococcus infections, can become resistant to antibiotics.

New understanding

Both penicillin and lysozyme work on bacteria cell walls. Penicillin weakens the cell walls of dividing bacteria, so that they burst and die due to osmotic pressure.

Lysozyme is a small enzyme that attacks the same protective cell wall of a bacterium, causing it to degrade.

The study from the Errington Lab, based at Newcastle University's Centre for Bacterial Cell Biology, has revealed exciting new features of both agents and how they can act in patients.

It is a development from previous work done in the Errington Lab on bacterial variants - called L-forms - which lack a cell wall and can grow if they have some protection, which human tissue allows.

The lab found that when bacteria are exposed to penicillin under conditions mimicking human tissue fluids they do not explode but slowly die because they are trapped in their own solidified wall.

If penicillin-treated cells in tissue fluid are exposed to lysozyme - found in places in the body where infections occur - the enzyme degrades the cell wall, allowing the bacterium to turn into a wall free L-form, which penicillin can't kill.

The formation of these antibiotic tolerant bacteria in patients could be a very important factor in allowing infection to recur.

Important implications

Professor Jeff Errington, lead author of the study, said: "Given Sir Alexander Fleming made his two major discoveries 80 or 90 years ago, you would expect that we knew pretty well how they worked.

"But our study has unearthed completely unexpected findings and significantly enhances our understanding of why some patients may find their infections relapse.

"The results of our study have important implications because they suggest that the L-form transition may be occurring frequently during infection.

"Although L-forms are much more fragile than walled cells, because they are completely resistant to penicillins and related antibiotics, they may be contributing substantially to problems of persistence or recurrence of infection, which is a frequent clinical problem.

"L-forms have been implicated in a range of chronic diseases but experts remain unconvinced as to how prevalent they are - our findings give clear evidence of their potential importance."
The study was funded by the European Research Council and further research at the Errington Lab is focusing on the importance of L-forms in recurrent urinary tract infections.


Lysozyme counteracts β-lactam antibiotics by promoting the emergence of L-form bacteria

Kawai, Mickiewicz and Errington, Centre for Bacterial Cell Biology, Newcastle University

Cell. DOI: 10.1016/j.cell.2018.01.021

Newcastle University

Related Bacteria Articles:

Conducting shell for bacteria
Under anaerobic conditions, certain bacteria can produce electricity. This behavior can be exploited in microbial fuel cells, with a special focus on wastewater treatment schemes.
Controlling bacteria's necessary evil
Until now, scientists have only had a murky understanding of how these relationships arise.
Bacteria take a deadly risk to survive
Bacteria need mutations -- changes in their DNA code -- to survive under difficult circumstances.
How bacteria hunt other bacteria
A bacterial species that hunts other bacteria has attracted interest as a potential antibiotic, but exactly how this predator tracks down its prey has not been clear.
Chlamydia: How bacteria take over control
To survive in human cells, chlamydiae have a lot of tricks in store.
Stress may protect -- at least in bacteria
Antibiotics harm bacteria and stress them. Trimethoprim, an antibiotic, inhibits the growth of the bacterium Escherichia coli and induces a stress response.
'Pulling' bacteria out of blood
Magnets instead of antibiotics could provide a possible new treatment method for blood infection.
New findings detail how beneficial bacteria in the nose suppress pathogenic bacteria
Staphylococcus aureus is a common colonizer of the human body.
Understanding your bacteria
New insight into bacterial cell division could lead to advancements in the fight against harmful bacteria.
Bacteria are individualists
Cells respond differently to lack of nutrients.

Related Bacteria Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...